- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Saphenous vein graft.
Displaying page 1 of 1.
EudraCT Number: 2014-002142-50 | Sponsor Protocol Number: POPCABG03 | Start Date*: 2019-04-09 |
Sponsor Name:St. Antonius Hospital | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery. | ||
Medical condition: Coronary artery bypass grafting surgery with the use of one or more saphenous vein grafts. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002343-30 | Sponsor Protocol Number: NEWTON-CABG | Start Date*: 2021-09-21 | |||||||||||
Sponsor Name:Unity Health Toronto, at its St. Michael’s site | |||||||||||||
Full Title: A randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery (NEWTON-CABG) | |||||||||||||
Medical condition: Patency of graft after coronary bypass graft surgery in patients with hyprelipidaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004214-16 | Sponsor Protocol Number: FS014 | Start Date*: 2005-01-19 | |||||||||||
Sponsor Name:Committee of Management, Common Services Agency T/A Scottish National Blood Transfusion Service | |||||||||||||
Full Title: A randomised control clinical study to determine whether SNBTS Fibrin Sealant promotes wound healing in patients undergoing cardiac surgery. | |||||||||||||
Medical condition: In patients undergoing cardiac surgery the saphenous leg vein is used to replace veins used in coronary artery bypass grafts (CABG) surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000013-36 | Sponsor Protocol Number: 49653/416 | Start Date*: 2005-08-17 |
Sponsor Name:Dr. Olivier F. Bertrand , Laval Hospital | ||
Full Title: A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression after Coronary Bypass Surgery in Diabetic Patients | ||
Medical condition: Atherosclerosis progression in vein grafts in diabetic patients after coronary bypass surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
